This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Søren Bjørn in Pharmaceutical Formulations
Introduction
Søren Bjørn is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of human growth hormone. His work is recognized for its potential impact on medical treatments and patient care.
Latest Patents
Søren holds a patent for a pharmaceutical formulation that includes an aqueous solution comprising human growth hormone, histidine, poloxamer, phenol, and mannitol. This innovative formulation aims to enhance the stability and efficacy of the hormone, which is crucial for various therapeutic applications.
Career Highlights
Søren Bjørn is associated with Novo Nordisk Healthcare AG, a leading company in the pharmaceutical industry. His role at the company has allowed him to work on groundbreaking research and development projects that focus on improving healthcare solutions.
Collaborations
Throughout his career, Søren has collaborated with esteemed colleagues such as Hans Holmegaard Sørensen and Peter Langballe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Søren Bjørn's contributions to pharmaceutical formulations exemplify the importance of innovation in healthcare. His work not only advances scientific knowledge but also has the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile